Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2007 3
2009 2
2010 1
2011 4
2012 1
2013 3
2014 4
2015 2
2016 6
2017 3
2018 1
2019 3
2020 3
2021 2
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumors.
Cinti S, Tomassi S, Ciardiello C, Migliorino R, Pirozzi M, Leone A, Di Gennaro E, Campani V, De Rosa G, D'Amore VM, Di Maro S, Donati G, Singh S, Raucci A, Di Leva FS, Kessler H, Budillon A, Marinelli L. Cinti S, et al. Among authors: di gennaro e. Commun Chem. 2024 Mar 21;7(1):60. doi: 10.1038/s42004-024-01144-z. Commun Chem. 2024. PMID: 38514757 Free PMC article.
New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer.
Costantini S, Madonna G, Di Gennaro E, Capone F, Bagnara P, Capone M, Sale S, Nicastro C, Atripaldi L, Fiorentino G, Parrella R, Montesarchio V, Atripaldi L, Ascierto PA, Budillon A. Costantini S, et al. Among authors: di gennaro e. Int J Mol Sci. 2023 Mar 3;24(5):4922. doi: 10.3390/ijms24054922. Int J Mol Sci. 2023. PMID: 36902351 Free PMC article.
Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection.
Costantini S, Di Gennaro E, Capone F, De Stefano A, Nasti G, Vitagliano C, Setola SV, Tatangelo F, Delrio P, Izzo F, Avallone A, Budillon A. Costantini S, et al. Among authors: di gennaro e. Front Oncol. 2023 Jan 11;12:1110104. doi: 10.3389/fonc.2022.1110104. eCollection 2022. Front Oncol. 2023. PMID: 36713567 Free PMC article.
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Roca MS, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, Camerlingo R, De Riso G, De Cecio R, Bruzzese F, Conte M, Altucci L, Di Gennaro E, Avallone A, Leone A, Budillon A. Roca MS, et al. Among authors: di gennaro e. J Exp Clin Cancer Res. 2022 Apr 11;41(1):138. doi: 10.1186/s13046-022-02324-2. J Exp Clin Cancer Res. 2022. PMID: 35410264 Free PMC article. No abstract available.
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Roca MS, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, Camerlingo R, De Riso G, De Cecio R, Bruzzese F, Conte M, Altucci L, Di Gennaro E, Avallone A, Leone A, Budillon A. Roca MS, et al. Among authors: di gennaro e. J Exp Clin Cancer Res. 2022 Mar 3;41(1):83. doi: 10.1186/s13046-022-02295-4. J Exp Clin Cancer Res. 2022. PMID: 35241126 Free PMC article.
Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Avallone A, Piccirillo MC, Nasti G, Rosati G, Carlomagno C, Di Gennaro E, Romano C, Tatangelo F, Granata V, Cassata A, Silvestro L, De Stefano A, Aloj L, Vicario V, Nappi A, Leone A, Bilancia D, Arenare L, Petrillo A, Lastoria S, Gallo C, Botti G, Delrio P, Izzo F, Perrone F, Budillon A. Avallone A, et al. Among authors: di gennaro e. JAMA Netw Open. 2021 Jul 1;4(7):e2118475. doi: 10.1001/jamanetworkopen.2021.18475. JAMA Netw Open. 2021. PMID: 34309665 Free PMC article. Clinical Trial.
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Iannelli F, Roca MS, Lombardi R, Ciardiello C, Grumetti L, De Rienzo S, Moccia T, Vitagliano C, Sorice A, Costantini S, Milone MR, Pucci B, Leone A, Di Gennaro E, Mancini R, Ciliberto G, Bruzzese F, Budillon A. Iannelli F, et al. Among authors: di gennaro e. J Exp Clin Cancer Res. 2020 Oct 8;39(1):213. doi: 10.1186/s13046-020-01723-7. J Exp Clin Cancer Res. 2020. PMID: 33032653 Free PMC article.
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.
Iannelli F, Zotti AI, Roca MS, Grumetti L, Lombardi R, Moccia T, Vitagliano C, Milone MR, Ciardiello C, Bruzzese F, Leone A, Cavalcanti E, De Cecio R, Iachetta G, Valiante S, Ionna F, Caponigro F, Di Gennaro E, Budillon A. Iannelli F, et al. Among authors: di gennaro e. Front Cell Dev Biol. 2020 Aug 17;8:732. doi: 10.3389/fcell.2020.00732. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33015030 Free PMC article.
42 results